Document and Entity Information
Document and Entity Information - shares | 6 Months Ended | |
Jun. 30, 2015 | Jul. 22, 2015 | |
Document and Entity Information [Abstract] | ||
Entity Registrant Name | AWARE INC /MA/ | |
Entity Central Index Key | 1,015,739 | |
Trading Symbol | awre | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 22,929,901 | |
Document Type | 10-Q | |
Document Period End Date | Jun. 30, 2015 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2,015 | |
Document Fiscal Period Focus | Q2 |
CONSOLIDATED BALANCE SHEETS (un
CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands | Jun. 30, 2015 | Dec. 31, 2014 |
Current assets: | ||
Cash and cash equivalents | $ 44,513 | $ 43,985 |
Accounts receivable, net | 4,821 | 3,619 |
Inventories | 2 | 2 |
Deferred tax assets | 189 | 168 |
Prepaid expenses and other current assets | 1,093 | 401 |
Total current assets | 50,618 | 48,175 |
Property and equipment, net | 5,140 | 5,289 |
Investments | 856 | 1,428 |
Long term deferred tax assets | 737 | 804 |
Other assets | 425 | 197 |
Total assets | 57,776 | 55,893 |
Current liabilities: | ||
Accounts payable | 147 | 258 |
Accrued expenses | 938 | 820 |
Deferred revenue | 2,836 | 2,352 |
Total current liabilities | 3,921 | 3,430 |
Long-term deferred revenue | $ 183 | $ 74 |
Commitments and contingent liabilities | ||
Stockholders' equity: | ||
Preferred stock, $1.00 par value; 1,000,000 shares authorized, none outstanding | ||
Common stock, $.01 par value; 70,000,000 shares authorized; issued and outstanding 22,871,039 as of June 30, 2015 and 22,808,761 as of December 31, 2014 | $ 229 | $ 228 |
Additional paid-in capital | 104,487 | 103,756 |
Accumulated other comprehensive loss | (69) | (29) |
Accumulated deficit | (50,975) | (51,566) |
Total stockholders' equity | 53,672 | 52,389 |
Total liabilities and stockholders' equity | $ 57,776 | $ 55,893 |
CONSOLIDATED BALANCE SHEETS (u3
CONSOLIDATED BALANCE SHEETS (unaudited) (Parentheticals) - $ / shares | Jun. 30, 2015 | Dec. 31, 2014 |
Statement Of Financial Position [Abstract] | ||
Preferred stock, par value (in dollars per share) | $ 1 | $ 1 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares outstanding | ||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 70,000,000 | 70,000,000 |
Common stock, shares issued | 22,871,039 | 22,808,761 |
Common stock, shares outstanding | 22,871,039 | 22,808,761 |
CONSOLIDATED STATEMENTS OF INCO
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Revenue: | ||||
Software licenses | $ 2,272 | $ 2,065 | $ 3,921 | $ 3,682 |
Software maintenance | 1,278 | 1,152 | 2,431 | 2,197 |
Services | 855 | 1,338 | 2,075 | 2,346 |
Hardware | 2,048 | 4,681 | ||
Royalties | 105 | 164 | 206 | 478 |
Total revenue | 4,510 | 6,767 | 8,633 | 13,384 |
Costs and expenses: | ||||
Cost of hardware | 1,411 | 3,313 | ||
Cost of services | 569 | 618 | 1,116 | 1,082 |
Research and development | 1,439 | 1,400 | 2,874 | 2,679 |
Selling and marketing | 1,064 | 981 | 2,036 | 1,839 |
General and administrative | 961 | 975 | 1,746 | 1,779 |
Total costs and expenses | 4,033 | 5,385 | 7,772 | 10,692 |
Operating income | 477 | 1,382 | 861 | 2,692 |
Other income/(expense) | (59) | 12 | (59) | |
Interest income | 33 | 52 | 74 | 139 |
Income before provision for income taxes | 510 | 1,375 | 947 | 2,772 |
Provision for income taxes | 191 | 510 | 356 | 1,026 |
Net income | $ 319 | $ 865 | $ 591 | $ 1,746 |
Net income per share - basic | $ 0.01 | $ 0.04 | $ 0.03 | $ 0.08 |
Net income per share - diluted | $ 0.01 | $ 0.04 | $ 0.03 | $ 0.08 |
Weighted-average shares - basic | 22,867 | 22,630 | 22,866 | 22,628 |
Weighted-average shares - diluted | 23,029 | 22,837 | 22,958 | 22,769 |
Comprehensive income: | ||||
Net income | $ 319 | $ 865 | $ 591 | $ 1,746 |
Other comprehensive income (net of tax): | ||||
Unrealized gains (losses) on available for sale securities | (48) | 37 | (40) | 121 |
Comprehensive income: | $ 271 | $ 902 | $ 551 | $ 1,867 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2015 | Jun. 30, 2014 | |
Cash flows from operating activities: | ||
Net income | $ 591 | $ 1,746 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 309 | 269 |
Stock-based compensation | 242 | 322 |
Amortization of premium on investments | (5) | |
Deferred tax provision on other comprehensive income | 21 | (79) |
(Gain)/loss on sale of investments | (12) | 59 |
Changes in assets and liabilities: | ||
Accounts receivable | (1,202) | (1,312) |
Inventories | 1,538 | |
Prepaid expenses and other current assets | (692) | 338 |
Deferred tax assets | 46 | 197 |
Accounts payable | (111) | (923) |
Accrued expenses | 118 | 170 |
Accrued income taxes | 88 | |
Deferred revenue | 593 | 270 |
Net cash provided by (used in) operating activities | (102) | 2,683 |
Cash flows from investing activities: | ||
Purchases of property and equipment | (68) | (101) |
Sales of investments | 529 | 1,432 |
Purchase of other assets | (320) | |
Net cash provided by investing activities | 141 | 1,331 |
Cash flows from financing activities: | ||
Proceeds from issuance of common stock | 22 | 68 |
Excess tax benefits from stock-based compensation | 554 | 592 |
Payments made for taxes of employees who surrendered shares related to unrestricted stock | (87) | (92) |
Net cash provided by financing activities | 489 | 568 |
Increase in cash and cash equivalents | 528 | 4,582 |
Cash and cash equivalents, beginning of period | 43,985 | 72,660 |
Cash and cash equivalents, end of period | 44,513 | 77,242 |
Supplemental disclosure: | ||
Cash paid for income taxes | 346 | 2 |
Non-cash transactions: | ||
Stock option receivables offset against proceeds from issuance of common stock | $ 0 | $ 138 |
Basis of Presentation
Basis of Presentation | 6 Months Ended |
Jun. 30, 2015 | |
Basis Of Accounting [Abstract] | |
Basis of Presentation | A) Basis of Presentation. The accompanying unaudited consolidated balance sheets, statements of income and comprehensive income, and statements of cash flows reflect all adjustments (consisting only of normal recurring items) which are, in the opinion of management, necessary for a fair presentation of financial position at June 30, 2015, and of operations and cash flows for the interim periods ended June 30, 2015 and 2014. The results of operations for the interim period ended June 30, 2015 are not necessarily indicative of the results to be expected for the year. |
Fair Value Measurements
Fair Value Measurements | 6 Months Ended |
Jun. 30, 2015 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | B) Fair Value Measurements. Cash and cash equivalents, which primarily include money market mutual funds, were $44.5 million and $44.0 million as of June 30, 2015 and December 31, 2014, respectively. We classified our cash equivalents of $34.3 million and $34.3 million as of June 30, 2015 and December 31, 2014 within Level 1 of the fair value hierarchy because they are valued using quoted market prices. Our investments, which consist of high yield corporate debt securities, are also classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. We categorize our investments as available-for-sale securities, and carry them at fair value in our financial statements. We had $0.9 million and $1.4 million of available-for-sale investments as of June 30, 2015 and December 31, 2014, respectively. As of June 30, 2015, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands): Fair Value Measurement at June 30, 2015 Using: Quoted Prices in Identical Assets Significant Other Significant (Level 1) (Level 2) (Level 3) Corporate debt securities $ 856 $ - $ - Money market funds (included in cash and cash equivalents) 34,311 Total $ 35,167 $ - $ - As of December 31, 2014, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands): Fair Value Measurement at December 31, 2014 Using: Quoted Prices in Identical Assets Significant Other Significant (Level 1) (Level 2) (Level 3) Corporate debt securities $ 1,428 $ - $ - Money market funds (included in cash and cash equivalents) 34,339 Total $ 35,767 $ - $ - |
Inventories
Inventories | 6 Months Ended |
Jun. 30, 2015 | |
Inventory Disclosure [Abstract] | |
Inventories | C) Inventories. |
Computation of Earnings per Sha
Computation of Earnings per Share | 6 Months Ended |
Jun. 30, 2015 | |
Earnings Per Share [Abstract] | |
Computation of Earnings per Share | D) Computation of Earnings per Share. Net income per share is calculated as follows (in thousands, except per share data): Three Months Ended June 30, Six Months Ended June 30, 2015 2014 2015 2014 Net income $ 319 $ 865 $ 591 $ 1,746 Shares outstanding Weighted-average common shares outstanding 22,867 22,630 22,866 22,628 Additional dilutive common stock equivalents 162 207 92 141 Diluted shares outstanding 23,029 22,837 22,958 22,769 Net income per share – basic $ 0.01 $ 0.04 $ 0.03 $ 0.08 Net income per share - diluted $ 0.01 $ 0.04 $ 0.03 $ 0.08 For the three month periods ended June 30, 2015 and 2014, options to purchase 54,034 and 821,838 shares of common stock were outstanding, but were not included in the computation of diluted EPS because the options’ exercise prices were greater than the average market price of the common stock and thus would be anti-dilutive. For the six month periods ended June 30, 2015 and 2014, options to purchase 54,034 and 821,838 shares of common stock, respectively, were outstanding, but were not included in the computation of diluted EPS because the options’ exercise prices were greater than the average market price of the common stock and thus would be anti-dilutive. |
Stock-Based Compensation
Stock-Based Compensation | 6 Months Ended |
Jun. 30, 2015 | |
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract] | |
Stock-Based Compensation | E) Stock-Based Compensation. Three Months Ended June 30, Six Months Ended June 30, 2015 2014 2015 2014 Cost of services $ 12 $ 14 $ 13 $ 15 Research and development 26 34 27 37 Selling and marketing 4 6 5 6 General and administrative 179 239 197 264 Stock-based compensation expense $ 221 $ 293 $ 242 $ 322 Stock Option Grants Unrestricted Stock Grants We granted shares of unrestricted stock in 2015 and 2014 that affected financial results for the three and six month periods ended June 30, 2015 and 2014. These grants are described below. 2015 Grant. 2014 Grant |
Business Segments
Business Segments | 6 Months Ended |
Jun. 30, 2015 | |
Segment Reporting [Abstract] | |
Business Segments | F) Business Segments We conduct our operations in the United States and sell our products and services to domestic and international customers. Revenues were generated from the following geographic regions for the three and six months ended June 30, 2015 and 2014 (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2015 2014 2015 2014 United States $ 2,526 $ 5,295 $ 5,014 $ 10,791 Brazil 928 398 1,654 437 Rest of World 1,056 1,074 1,965 2,156 $ 4,510 $ 6,767 $ 8,633 $ 13,384 Revenue by product group for the three and six months ended June 30, 2015 and 2014 was (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2015 2014 2015 2014 Biometrics $ 3,883 $ 6,029 $ 7,731 $ 12,210 Imaging 522 574 696 697 DSL royalties 105 164 206 477 $ 4,510 $ 6,767 $ 8,633 $ 13,384 |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 6 Months Ended |
Jun. 30, 2015 | |
Accounting Changes and Error Corrections [Abstract] | |
Recent Accounting Pronouncements | G) Recent Accounting Pronouncements. With the exception of the new revenue standard discussed above, there have been no other recently issued accounting pronouncements that are of significance or potential significance to us that we have not adopted as of June 30, 2015. |
Income Taxes
Income Taxes | 6 Months Ended |
Jun. 30, 2015 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | H) Income Taxes. Income tax expense was $0.2 million and $0.5 million for the three months ended June 30, 2015 and 2014, respectively. Income tax expense was $0.4 million and $1.0 million for the six months ended June 30, 2015 and 2014, respectively. Income tax expense in the three and six month periods of 2015 and 2014 was based on the U.S. statutory rate of 34%, increased by state income taxes. In the six month periods ended June 30, 2015 and 2014, we utilized deferred tax assets to reduce our tax liability payable to the government. A portion of the deferred tax assets we used comprised cumulative deductions for stock options in excess of book expense. Under income tax accounting rules, that portion of tax benefits attributable to such deductions must be recorded as an adjustment to equity versus a reduction of income tax expense. The tax benefits from such stock-based awards were $0.6 million and $0.6 million in the six month periods ended June 30, 2015 and 2014, respectively. These tax benefits were recorded as an equity adjustment to additional paid-in capital. As of June 30, 2015, we had a total of $0.9 million of deferred tax assets for which we had recorded no valuation allowance. We will continue to assess the level of valuation allowance in future periods. Should evidence regarding the realizability of tax assets change at a future point in time, the valuation allowance will be adjusted accordingly. In addition to deferred tax assets carried on our balance sheet, we also had net federal and state research and development credit carryforwards available at December 31, 2014 of $4.0 million and $0.3 million. These credits were not recorded as tax assets as they relate to excess stock compensation deductions that may not be recorded as tax assets under generally accepted accounting principles until the amounts have been utilized to reduce our tax liability. To the extent that these assets are used to reduce future taxes, the benefit will be recorded as a reduction to additional paid-in capital. The aforementioned $0.6 million and $0.6 million The Internal Revenue Service commenced an examination of our tax return for the year ended December 31, 2012 in September 2014. |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Loss | 6 Months Ended |
Jun. 30, 2015 | |
Equity [Abstract] | |
Accumulated Other Comprehensive Loss | I) Accumulated Other Comprehensive Loss. December 31, Increase/ Reclassification June 30, Unrealized losses on available for sale securities ($ 87 ) ($ 63 ) $ - ($ 150 ) Unrealized gains on available for sale securities 43 (10 ) 12 45 Net unrealized gains (losses) on available for sale securities (44 ) (73 ) 12 (a) (105 ) Income tax benefit (expense) on other comprehensive loss 15 25 (4 ) 36 Total accumulated other comprehensive loss, net of taxes ($ 29 ) ($ 48 ) $ 8 ($ 69 ) (a) – Classified in other income. |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 6 Months Ended |
Jun. 30, 2015 | |
Fair Value Disclosures [Abstract] | |
Schedule of assets measured at fair value on a recurring basis | Fair Value Measurement at June 30, 2015 Using: Quoted Prices in Identical Assets Significant Other Significant (Level 1) (Level 2) (Level 3) Corporate debt securities $ 856 $ - $ - Money market funds (included in cash and cash equivalents) 34,311 Total $ 35,167 $ - $ - Fair Value Measurement at December 31, 2014 Using: Quoted Prices in Identical Assets Significant Other Significant (Level 1) (Level 2) (Level 3) Corporate debt securities $ 1,428 $ - $ - Money market funds (included in cash and cash equivalents) 34,339 Total $ 35,767 $ - $ - |
Computation of Earnings per S16
Computation of Earnings per Share (Tables) | 6 Months Ended |
Jun. 30, 2015 | |
Earnings Per Share [Abstract] | |
Schedule of net income per share | Three Months Ended June 30, Six Months Ended June 30, 2015 2014 2015 2014 Net income $ 319 $ 865 $ 591 $ 1,746 Shares outstanding Weighted-average common shares outstanding 22,867 22,630 22,866 22,628 Additional dilutive common stock equivalents 162 207 92 141 Diluted shares outstanding 23,029 22,837 22,958 22,769 Net income per share – basic $ 0.01 $ 0.04 $ 0.03 $ 0.08 Net income per share - diluted $ 0.01 $ 0.04 $ 0.03 $ 0.08 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 6 Months Ended |
Jun. 30, 2015 | |
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract] | |
Schedule of stock-based employee compensation expense included in unaudited consolidated statements of comprehensive income | Three Months Ended June 30, Six Months Ended June 30, 2015 2014 2015 2014 Cost of services $ 12 $ 14 $ 13 $ 15 Research and development 26 34 27 37 Selling and marketing 4 6 5 6 General and administrative 179 239 197 264 Stock-based compensation expense $ 221 $ 293 $ 242 $ 322 |
Business Segments (Tables)
Business Segments (Tables) | 6 Months Ended |
Jun. 30, 2015 | |
Segment Reporting [Abstract] | |
Schedule of revenues generated from geographic regions | Three Months Ended Six Months Ended June 30, June 30, 2015 2014 2015 2014 United States $ 2,526 $ 5,295 $ 5,014 $ 10,791 Brazil 928 398 1,654 437 Rest of World 1,056 1,074 1,965 2,156 $ 4,510 $ 6,767 $ 8,633 $ 13,384 |
Schedule of revenue by product group | Three Months Ended Six Months Ended June 30, June 30, 2015 2014 2015 2014 Biometrics $ 3,883 $ 6,029 $ 7,731 $ 12,210 Imaging 522 574 696 697 DSL royalties 105 164 206 477 $ 4,510 $ 6,767 $ 8,633 $ 13,384 |
Accumulated Other Comprehensi19
Accumulated Other Comprehensive Loss (Tables) | 6 Months Ended |
Jun. 30, 2015 | |
Equity [Abstract] | |
Schedule of components of accumulated other comprehensive loss and activity | December 31, Increase/ Reclassification June 30, Unrealized losses on available for sale securities ($ 87 ) ($ 63 ) $ - ($ 150 ) Unrealized gains on available for sale securities 43 (10 ) 12 45 Net unrealized gains (losses) on available for sale securities (44 ) (73 ) 12 (a) (105 ) Income tax benefit (expense) on other comprehensive loss 15 25 (4 ) 36 Total accumulated other comprehensive loss, net of taxes ($ 29 ) ($ 48 ) $ 8 ($ 69 ) (a) – Classified in other income. |
Fair Value Measurements - Asset
Fair Value Measurements - Assets measured at fair value on a recurring basis (Details) - Fair value on recurring basis - USD ($) $ in Thousands | Jun. 30, 2015 | Dec. 31, 2014 |
Fair Value Measurement, Significant Other Observable Inputs (Level 2) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets measured at fair value | ||
Fair Value Measurement, Significant Other Observable Inputs (Level 2) | Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Corporate debt securities | ||
Fair Value Measurement, Significant Other Observable Inputs (Level 2) | Money market funds (included in cash and cash equivalents) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money market funds (included in cash and cash equivalents) | ||
Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets measured at fair value | $ 35,167 | $ 35,767 |
Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Corporate debt securities | 856 | 1,428 |
Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market funds (included in cash and cash equivalents) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money market funds (included in cash and cash equivalents) | $ 34,311 | $ 34,339 |
Fair Value Measurement, Significant Unobservable Inputs (Level 3) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total assets measured at fair value | ||
Fair Value Measurement, Significant Unobservable Inputs (Level 3) | Corporate debt securities | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Corporate debt securities | ||
Fair Value Measurement, Significant Unobservable Inputs (Level 3) | Money market funds (included in cash and cash equivalents) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money market funds (included in cash and cash equivalents) |
Fair Value Measurements (Detail
Fair Value Measurements (Detail Textuals) - USD ($) $ in Thousands | Jun. 30, 2015 | Dec. 31, 2014 | Jun. 30, 2014 | Dec. 31, 2013 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Cash and cash equivalents, primarily include money market funds | $ 44,513 | $ 43,985 | $ 77,242 | $ 72,660 |
Fair value on recurring basis | Corporate debt securities | Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Available-for-sale investments | 856 | 1,428 | ||
Fair value on recurring basis | Money market funds (included in cash and cash equivalents) | Fair Value Measurement, Quoted Prices in Active Markets for Identical Assets (Level 1) | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Cash and cash equivalents, primarily include money market funds | $ 34,300 | $ 34,300 |
Computation of Earnings per S22
Computation of Earnings per Share - Summary of net income per share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Earnings Per Share [Abstract] | ||||
Net income | $ 319 | $ 865 | $ 591 | $ 1,746 |
Shares outstanding: | ||||
Weighted average common shares outstanding (in shares) | 22,867 | 22,630 | 22,866 | 22,628 |
Additional dilutive common stock equivalents (in shares) | 162 | 207 | 92 | 141 |
Diluted shares outstanding (in shares) | 23,029 | 22,837 | 22,958 | 22,769 |
Net income per share - basic | $ 0.01 | $ 0.04 | $ 0.03 | $ 0.08 |
Net income per share - diluted | $ 0.01 | $ 0.04 | $ 0.03 | $ 0.08 |
Computation of Earnings per S23
Computation of Earnings per Share (Detail Textuals) - shares | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Options | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Anti-dilutive common stock Share purchase (in shares) | 54,034 | 821,838 | 54,034 | 821,838 |
Stock-Based Compensation - Summ
Stock-Based Compensation - Summary of stock-based employee compensation expenses (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation | $ 221 | $ 293 | $ 242 | $ 322 |
Cost of services | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation | 12 | 14 | 13 | 15 |
Research and development | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation | 26 | 34 | 27 | 37 |
Selling and marketing | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation | 4 | 6 | 5 | 6 |
General and administrative | ||||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||||
Stock-based compensation | $ 179 | $ 239 | $ 197 | $ 264 |
Stock-Based Compensation (Detai
Stock-Based Compensation (Detail Textuals) - Unrestricted Stock Grants - 2001 Nonqualified Stock Plan - Directors, officers and employees - USD ($) | Jul. 01, 2015 | Jul. 01, 2014 | Mar. 26, 2015 | Jan. 31, 2015 | Mar. 31, 2014 | Jun. 30, 2015 | Jun. 30, 2015 | Dec. 31, 2014 |
2014 Grant | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Number of shares granted (in shares) | 152,000 | |||||||
Stock-based compensation expense | $ 876,000 | |||||||
Number of shares issued (in shares) | 58,769 | 56,804 | ||||||
Number of common stock shares surrendered by employees withholding taxes | 17,231 | 19,196 | ||||||
Common stock value surrendered by employees withholding taxes | $ 113,000 | $ 87,000 | ||||||
2015 Grant | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Number of shares granted (in shares) | 152,000 | |||||||
Number of shares issuable in future | 76,000 | |||||||
Stock-based compensation expense | $ 682,000 | |||||||
Stock based compensation expense charged | $ 221,000 | 236,000 | ||||||
Remaining stock based compensation expense | $ 446,000 | $ 446,000 | ||||||
2015 Grant | Subsequent Event | ||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||
Number of shares issued (in shares) | 76,000 |
Business Segments - Revenues ge
Business Segments - Revenues generated following geographic regions (Details ) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Segment Reporting Information [Line Items] | ||||
Revenue | $ 4,510 | $ 6,767 | $ 8,633 | $ 13,384 |
Operating Segments | United States | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 2,526 | 5,295 | 5,014 | 10,791 |
Operating Segments | Brazil | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 928 | 398 | 1,654 | 437 |
Operating Segments | Rest of World | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | $ 1,056 | $ 1,074 | $ 1,965 | $ 2,156 |
Business Segments - Summary of
Business Segments - Summary of revenue by product group (Details 1) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | |
Segment Reporting Information [Line Items] | ||||
Revenue | $ 4,510 | $ 6,767 | $ 8,633 | $ 13,384 |
Operating Segments | Biometrics | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 3,883 | 6,029 | 7,731 | 12,210 |
Operating Segments | Imaging | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | 522 | 574 | 696 | 697 |
Operating Segments | DSL royalties | ||||
Segment Reporting Information [Line Items] | ||||
Revenue | $ 105 | $ 164 | $ 206 | $ 477 |
Income Taxes (Detail Textuals)
Income Taxes (Detail Textuals) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2015 | Jun. 30, 2014 | Jun. 30, 2015 | Jun. 30, 2014 | Dec. 31, 2014 | |
Operating Loss Carryforwards [Line Items] | |||||
Income tax expense | $ 191 | $ 510 | $ 356 | $ 1,026 | |
Income tax U.S. statutory rate | 34.00% | 34.00% | 34.00% | 34.00% | |
Tax benefits from stock-based awards | $ 600 | $ 600 | |||
Deferred tax assets | $ 900 | 900 | |||
Equity adjustment to additional paid-in capital | $ 600 | $ 600 | |||
Federal | Research and development credit carryforwards | |||||
Operating Loss Carryforwards [Line Items] | |||||
Net federal and state research and development credit carryforwards | $ 4,000 | ||||
State | Research and development credit carryforwards | |||||
Operating Loss Carryforwards [Line Items] | |||||
Net federal and state research and development credit carryforwards | $ 300 |
Accumulated Other Comprehensi29
Accumulated Other Comprehensive Loss - Components of accumulated other comprehensive loss and activity (Details) $ in Thousands | 6 Months Ended | |
Jun. 30, 2015USD ($) | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance Net unrealized gains (losses) on available for sale securities | $ (44) | |
Beginning balance Income tax benefit (expense) on other comprehensive loss | 15 | |
Beginning balance Total accumulated other comprehensive loss, net of taxes | (29) | |
Increase/Decrease Net unrealized gains (losses) on available for sale securities | (73) | |
Increase/Decrease Income tax benefit (expense) on other comprehensive loss | 25 | |
Increase/Decrease Total accumulated other comprehensive loss, net of taxes | (48) | |
Reclassification Adjustments Net unrealized gains (losses) on available for sale securities | [1] | 12 |
Reclassification Adjustments Income tax benefit (expense) on other comprehensive loss | (4) | |
Reclassification Adjustments Total accumulated other comprehensive loss, net of taxes | 8 | |
Ending balance Net unrealized gains (losses) on available for sale securities | (105) | |
Ending balance Income tax benefit (expense) on other comprehensive loss | 36 | |
Ending balance Total accumulated other comprehensive loss, net of taxes | (69) | |
Unrealized losses on available for sale securities | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance Net unrealized gains (losses) on available for sale securities | (87) | |
Increase/Decrease Net unrealized gains (losses) on available for sale securities | $ (63) | |
Reclassification Adjustments Net unrealized gains (losses) on available for sale securities | ||
Ending balance Net unrealized gains (losses) on available for sale securities | $ (150) | |
Unrealized gains on available for sale securities | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Beginning balance Net unrealized gains (losses) on available for sale securities | 43 | |
Increase/Decrease Net unrealized gains (losses) on available for sale securities | (10) | |
Reclassification Adjustments Net unrealized gains (losses) on available for sale securities | 12 | |
Ending balance Net unrealized gains (losses) on available for sale securities | $ 45 | |
[1] | Classified in other income. |